Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astragalus and Zedoary is a Traditional Chinese Medicine (TCM) herbal combination consisting of the roots of *Astragalus membranaceus* (Huangqi) and the rhizomes of *Curcuma zedoaria* (Ezhu). This herb pair is frequently utilized in TCM for its synergistic effects in tonifying Qi and invigorating blood to remove stasis. In the context of oncology and gastroenterology, it is investigated for its potential to inhibit the progression of precancerous gastric lesions, such as gastric atrophy and intestinal metaplasia, to gastric cancer. The mechanism involves immunomodulation, inhibition of cell proliferation, induction of apoptosis, and regulation of the tumor microenvironment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astragalus + zedoary.